what is glp-1 drug made from Compounded" drugs | Health Communication Research Laboratory GLP-1 drugs protect against new

EMPEROR-Reduced included 1,188 (64%) patients treated with JARDIANCE 65 years of age and older, and 503 (27%) patients 75 years of age and older

Association of glucagon-like peptide-1 receptor agonists with acute pancreatitis and biliary disease in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study

JAMA Intern Med 182 , 513519 (2022)

The requirements include patients at high metabolic or cardiovascular risk with a BMI greater than 27 with prediabetes or established cardiovascular disease, or a BMI over 30 with uncontrolled hypertension despite treatment, advanced kidney disease, or heart failure

These medications have been tested and shown to be safe and effective for obesity

Lin H-T, Tsai Y-F, Liao P-L, Wei JCC